To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: MICroSTREP Panel, New Strep Testing Procedure Cleared by FDA URL: http://www.pslgroup.com/dg/F66E.htm Doctor's Guide December 26, 1996
WEST SACRAMENTO, Calif.—Dec. 26, 1996 -- Dade MicroScan Inc. has received FDA clearance for the Dade MICroSTREP(TM) Panel, a new testing procedure for antimicrobial susceptibility of three different classes of streptococcus including Streptococcus pneumoniae, viridans streptococci and beta-hemolytic streptococci. The new Dade procedure tests all major non-enterococcal streptococci with a single panel. The frozen microdilution technique of the Dade MICroSTREP Panel follows NCCLS guidelines and offers greater than 99% agreement without limitations to the NCCLS reference method. This procedure also is the only broth microdilution panel that incorporates the new NCCLS M100-S6 endpoints. The new method of testing includes all NCCLS-recommended primary antimicrobics on one panel. These ten antimicrobial agents provide more diagnostic information in a single procedure than has been previously available. "Streptococcal isolates that are resistant to traditional antimicrobial therapy are being more frequently reported by clinicians," according to John Groat, marketing manager at Dade MicroScan. "The need for susceptibility testing to determine alternative treatments has never been greater," adds Groat. The Dade MICroSTREP Panel offers clear and concise endpoints which provide a definitive MIC value. The panels, which can be read manually in any microbiology lab, increase accuracy by reducing operator error. Dade MicroScan, Inc., a division of Dade International, is headquartered in West Sacramento and is a leader in microbiology identification and antibiotic susceptibility testing. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.